| Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. | |
| | |
MedLine Citation:
|
PMID: 17716335 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: Prader-Willi syndrome (PWS) is a neurogenetic disorder characterized by muscular hypotonia, psychomotor delay, obesity and short stature. Several endocrine abnormalities have been described, including GH deficiency and hypogonadotrophic hypogonadism. Published data on thyroid hormone levels in PWS children are very limited. OBJECTIVE: To evaluate thyroid function in children with PWS, before and during GH treatment. DESIGN/PATIENTS: At baseline, serum levels of T4, free T4 (fT4), T3, reverse T3 (rT3) and TSH were assessed in 75 PWS children. After 1 year, assessments were repeated in 57 of the them. These children participated in a randomized study with two groups: group A (n = 34) treated with 1 mg GH/m(2)/day and group B (n = 23) as controls. RESULTS: Median age (interquartile range, IQR) of the total group at baseline was 4.7 (2.7-7.6) years. Median (IQR) TSH level was -0.1 SDS (-0.5 to 0.5), T4 level -0.6 SDS (-1.7 to 0.0) and fT4 level -0.8 SDS (-1.3 to -0.3), the latter two being significantly lower than 0 SDS. T3 level, at 0.3 SDS (-0.3 to 0.9), was significantly higher than 0 SDS. After 1 year of GH treatment, fT4 decreased significantly from -0.8 SDS (-1.5 to -0.2) to -1.4 SDS (-1.6 to -0.7), compared to no change in untreated PWS children. However, T3 did not change, at 0.3 SDS (-0.1 to 0.8). CONCLUSIONS: We found normal fT4 levels in most PWS children. During GH treatment, fT4 decreased significantly to low-normal levels. TSH levels remained normal. T3 levels were relatively high or normal, both before and during GH treatment, indicating that PWS children have increased T4 to T3 conversion. |
| | |
Authors:
|
D A M Festen; T J Visser; B J Otten; J M Wit; H J Duivenvoorden; A C S Hokken-Koelega |
Related Documents
:
|
3215145 - Effects of low dose l-triiodothyronine administration on mental, behavioural and thyroi... 3140015 - Paracoccidioidomycosis in the region of botucatu (state of são paulo, brazil). evaluat... 6708815 - Propylthiouracil, ipodate, dexamethasone and periods of fasting induce different variat... 3596465 - Pitfalls in the interpretation of thyroid function tests in old age and non-thyroidal i... 17422245 - The effects of gonadotrophin releasing hormone administration in early postpartum dairy... 22291765 - The way of serum chromium utilization may contribute to cardiovascular risk factors in ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical endocrinology Volume: 67 ISSN: 0300-0664 ISO Abbreviation: Clin. Endocrinol. (Oxf) Publication Date: 2007 Sep |
Date Detail:
|
Created Date: 2007-08-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0346653 Medline TA: Clin Endocrinol (Oxf) Country: England |
Other Details:
|
Languages: eng Pagination: 449-56 Citation Subset: IM |
Affiliation:
|
Dutch Growth Foundation, Rotterdam, The Netherlands. d.festen@erasmusmc.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Meningitis after percutaneous radiofrequency trigeminal ganglion lesion. Case report and review of l...
Next Document: Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the availabl...